Shares of Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) saw an uptick in trading volume on Wednesday . 2,022 shares were traded during trading, an increase of 239% from the previous session’s volume of 596 shares.The stock last traded at $120.00 and had previously closed at $119.31.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group lowered Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $155.00.
View Our Latest Stock Analysis on PMCUF
Pro Medicus Stock Performance
About Pro Medicus
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Featured Articles
- Five stocks we like better than Pro Medicus
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
- Lithia’s Record Quarter Keeps the Bull Case Alive
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
